Project information
Identification of new treatment options for achondroplasia through the analysis of interaction between FGFR3 and adapter protein Frs2
- Project Identification
- 15-33232A (kod CEP: NV15-33232A)
- Project Period
- 5/2015 - 12/2018
- Investor / Pogramme / Project type
-
Ministry of Health of the CR
- Programme NV (2015 - 2022)
- MU Faculty or unit
- Faculty of Medicine
Activating mutations in the FGFR3 receptor tyrosine kinase cause the most common form of dwarfism in humans, achondroplasia. Excessive activation of FGFR3 causes premature termination of chondrocyte growth, abnormal extracellular matrix homeostasis and abnormal chondrocyte differentiation, leading to achondroplasia. Although achondroplasia is considered a treatable condition, no treatment currently exists. This is primarily due to our lack of understanding of the fundamental mechanisms governing FGFR3 signal transduction in cartilage. Uncontrolled activation of the Erk MAP kinase, mediated by the signalling adaptor protein Frs2, represents the main mediator of FGFR3 activation in achondroplasia. The molecular mechanisms underlying this phenotype are unknown. The dynamics of the interaction between Frs2 and FGFR3, Erk and other proteins represent a key to understanding the pathology of achondroplasia, and are addressed in this proposal. Through the systematic mapping of interactions between FGFR3, Frs2, Erk and other proteins, we aim to identify new treatment options for achondroplasia.
Publications
Total number of publications: 21
2019
-
Fibroblast growth factor receptor influences primary cilium length through an interaction with intestinal cell kinase
Proceedings of the National Academy of Sciences of the United States of America, year: 2019, volume: 116, edition: 10, DOI
2018
-
Advances in the cellular structural biology of nucleic acids
FEBS LETTERS, year: 2018, volume: 592, edition: 12, DOI
-
Nanodiamonds as "artificial proteins": Regulation of a cell signalling system using low nanomolar solutions of inorganic nanocrystals
Biomaterials, year: 2018, volume: 176, edition: SEP 2018, DOI
-
Proteomic analyses of signalling complexes associated with receptor tyrosine kinase identify novel members of fibroblast growth factor receptor 3 interactome
Cellular Signalling, year: 2018, volume: 42, edition: JAN 2018, DOI
-
Registr Achondroplasie na Slovensku a v České republice
Year: 2018, type: Requested lectures
-
Registr Achondroplázie REACH
Year: 2018, type: Requested lectures
-
Regulation of ciliary function by fibroblast growth factor signaling identifies FGFR3-related disorders achondroplasia and thanatophoric dysplasia as ciliopathies
Human molecular genetics, year: 2018, volume: 27, edition: 6, DOI
-
The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinases
SCIENCE SIGNALING, year: 2018, volume: 11, edition: 548, DOI
-
The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling
Science Translational Medicine, year: 2018, volume: 10, edition: 459, DOI
2017
-
A Novel Role for the BMP Antagonist Noggin in Sensitizing Cells to Non-canonical Wnt-5a/Ror2/Disheveled Pathway Activation
Frontiers in Cell and Developmental Biology, year: 2017, volume: 5, edition: MAY, DOI